UBS AM’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-161,515
| Closed | -$22.6M | – | 2843 |
|
|
2018
Q4 | $22.6M | Sell |
161,515
-647
| -0.4% | -$90.6K | 0.02% | 680 |
|
|
2018
Q3 | $27.7M | Sell |
162,162
-20,352
| -11% | -$3.48M | 0.02% | 669 |
|
|
2018
Q2 | $31.7M | Sell |
182,514
-16,694
| -8% | -$2.9M | 0.02% | 652 |
|
|
2018
Q1 | $23M | Sell |
199,208
-12,026
| -6% | -$1.39M | 0.02% | 732 |
|
|
2017
Q4 | $17.8M | Buy |
211,234
+4,193
| +2% | +$353K | 0.02% | 779 |
|
|
2017
Q3 | $19.1M | Sell |
207,041
-33,297
| -14% | -$3.07M | 0.02% | 737 |
|
|
2017
Q2 | $19.3M | Buy |
240,338
+63,678
| +36% | +$5.11M | 0.02% | 752 |
|
|
2017
Q1 | $7.43M | Sell |
176,660
-39,296
| -18% | -$1.65M | 0.01% | 952 |
|
|
2016
Q4 | $6.94M | Sell |
215,956
-14,619
| -6% | -$470K | 0.01% | 931 |
|
|
2016
Q3 | $6.04M | Buy |
230,575
+21,477
| +10% | +$562K | 0.01% | 986 |
|
|
2016
Q2 | $4.85M | Buy |
209,098
+128,754
| +160% | +$2.98M | 0.01% | 1021 |
|
|
2016
Q1 | $2.2M | Buy |
+80,344
| New | +$2.2M | ﹤0.01% | 1328 |
|